Financial Daily from THE HINDU group of publications
Thursday, Nov 04, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Industry & Economy - Health


Paswan against drug price control provided consumers not hurt

Our Bureau


Mr Ram Vilas Paswan, Minister for Chemicals and Fertilisers, flanked by Mr Nikhil Meswani (right), Executive Director, Reliance Industries Ltd, and Mr Onkar S. Kanwar, Senior Vice-President, FICCI, at the inaugural function of India Chem 2004 held in Mumbai on Wednesday. - Paul Noronha

Mumbai , Nov. 3

EVEN as the Government attempts to rein in the prices of generic medicines, the Union Minister for Chemicals and Fertilisers, Mr Ram Vilas Paswan, said on Wednesday that he was not for price control on drugs, as long as the prices did not hurt consumers.

An interim report on the drug pricing issue has been submitted on October 31 to the Department of Chemicals and Petrochemicals, he told media persons at the India Chem 2004 event in Mumbai. Details of the internally generated report were being examined by the department, he added.

The Minister said that he was "against price control," provided the consumer was not hurt by escalating medicine prices.

Taking into account the cost of production incurred by drug companies, he urged pharma companies to exercise "self-control" over their prices, so that generic or chemically-equivalent medicines would not be as expensive at the original branded medicine.

He admitted that monitoring authorities were in place to intervene in medicine prices if they reflected unnatural inflationary trends.

Mr Paswan had turned the heat on generic pharma companies, when he raised the issue of high prices in medicines that were copies of branded medicines.

The concern particularly was in critical segments, such as cancer and anti-AIDS drugs, Ministry officials said.

More Stories on : Health | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Bill on job guarantee likely in winter session


`Job reservation will not be imposed on pvt sector'
Dumping probe on sodium cyanide initiated
I&B Ministry to showcase progress of CMP
Central Excise customers' education programme in Mangalore
Nigerian President woos Indian investment
India-Turkey trade to touch $1 b this year
Wockhardt Hospitals releases patients' rights document
Paswan against drug price control provided consumers not hurt
Meet on magnetic resonance in Hyderabad
Keral Govt begins land acquisition for fast-track infrastructure projects
Cabinet approves formation of board for PSEs' revamp
Cabinet rejects death penalty for spurious drug makers
Drug affordability tops WHO panel's agenda
Competition will control drug prices: IDMA
Massive investments needed to augment power capacity in Maharashtra
CCEA revises cost of Tehri project phase-I
Economists urge debate on VAT issues
TN textile industry gets lion's share in TUFS
`Legislation for SSI soon'
Plea to AP SSI units
Finalise changes in WALT Act, YSR tells officials
Ingersoll Rand offers PG course on road technology
German grant for Hyderabad varsity
College infrastructure seminar in Mangalore
Study predicts upward rise in real estate prices
BrahMos anti-ship missile tested
Nasscom marketing drive
Rubber exports may decline



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line